ATUS (ATUS) insider Dexter Goei plans Rule 144 sale of 349,582 shares

Rhea-AI Filing Summary

Dexter Goei has filed a notice of proposed sale of common stock under Rule 144 for issuer ATUS. The filing states an intention to sell 349,582 common shares through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 12/05/2025. The table notes that 285,388,630 shares of this class are outstanding.

The securities to be sold were acquired on 06/08/2018 through a profit interest program from the issuer as compensation. The filing also lists recent sales by Dexter Goei over the past three months, including 695,195 common shares sold on 11/26/2025 and additional sales on 12/01/2025, 12/02/2025, 12/03/2025, and 12/04/2025 with specified gross proceeds.

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK
Filer CCC
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer

SEC File Number

Address of Issuer

Phone

Name of Person for Whose Account the Securities are To Be Sold

See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.

Relationship to Issuer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	349582	665114.71	285388630	12/05/2025	NYSE

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	06/08/2018	Profit Interest Program	Issuer			349582	06/08/2018	Compensation

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
DEXTER GOEI 1111 Stewart Avenue Bethpage NY 11714	Common	12/04/2025	109505	208683.68
DEXTER GOEI 1111 Stewart Avenue Bethpage NY 11714	Common	12/03/2025	114410	217401.88
DEXTER GOEI 1111 Stewart Avenue Bethpage NY 11714	Common	12/02/2025	32228	61233.20
DEXTER GOEI 1111 Stewart Avenue Bethpage NY 11714	Common	12/01/2025	184898	355318.49
DEXTER GOEI 1111 Stewart Avenue Bethpage NY 11714	Common	11/26/2025	695195	1324068.40

144: Remarks and Signature

Remarks

Date of Notice

ATTENTION:

The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.

Signature

ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)

FAQ

What does this Form 144 filing for ATUS disclose?

It discloses that Dexter Goei plans to sell 349,582 common shares of ATUS under Rule 144 through Morgan Stanley Smith Barney LLC on the NYSE, with an approximate sale date of 12/05/2025.

How many ATUS shares are planned to be sold and through which broker?

The filing indicates a planned sale of 349,582 common shares of ATUS through Morgan Stanley Smith Barney LLC Executive Financial Services on the NYSE.

How and when did Dexter Goei acquire the ATUS shares being sold?

The shares to be sold were acquired as common stock on 06/08/2018 via a Profit Interest Program from the issuer, with the nature of payment described as compensation.

How many ATUS shares of this class are outstanding according to the filing?

The securities information table reports that there are 285,388,630 common shares outstanding for this class of ATUS stock.

What ATUS share sales has Dexter Goei made in the past three months?

The filing lists several recent sales of ATUS common stock by Dexter Goei, including 695,195 shares on 11/26/2025, 184,898 shares on 12/01/2025, 32,228 shares on 12/02/2025, 114,410 shares on 12/03/2025, and 109,505 shares on 12/04/2025, each with corresponding gross proceeds.

What representation does the seller make in this ATUS Form 144 notice?

By signing, the seller represents that they do not know any material adverse information about the issuer’s current and prospective operations that has not been publicly disclosed and acknowledges that intentional misstatements or omissions constitute federal criminal violations.